Skip to main content

Advertisement

Log in

Nocturia and its impact on health-related quality of life and health care seeking behaviour in German community-dwelling men aged 50 years or older

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the prevalence of nocturia/nocturnal voiding frequency and its impact on overall physical and mental health status in German community-dwelling men and determine which lower urinary tract symptom (LUTS) is responsible for medical consultations in the 2-year follow-up period.

Methods

A sample of German men aged 50–80 years from a community-dwelling study was chosen for re-evaluation 2 years after initial assessment. Men were clinically investigated and completed the International Prostate Symptom Score, American Urology Association-Symptom Problem Index (AUA-SPI), and the Short-Form Health Survey (SF-12).

Results

In total, 1,562 men were eligible for analysis. Mean nocturnal voiding frequency was 2.3 for all men and increased with ageing. SF-12 data indicated that physical but not mental health status was lower than in the average population. LUTS severity reduced both physical and mental health status (p < 0.001). Clinically relevant nocturia (≥2 voids/night) was present in 43 % of men and reduced both physical and mental health status (p < 0.001), whereas both HRQoL scales were not significantly reduced in men without or only one nocturnal void. In multivariate regression analysis using patient-reported bother (AUA-SPI) from LUTS, only bother from nocturnal voiding was significantly associated with medical consultations in the investigated 2-year follow-up period (odds ratio 2.6; 95 % confidence interval 1.6–4.2; p < 0.001).

Conclusions

Our study confirmed that nocturnal voiding is highly prevalent in community-dwelling men and reduce both physical and mental health status. Bother from nocturnal voiding is the most relevant component of LUTS responsible for medical consultations in German men.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S et al (2002) The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:179–183

    Article  PubMed  Google Scholar 

  2. Norgaard JP (2010) The role of nocturia in the quality of life of men with lower urinary tract symptoms. BJU Int 105:1016–1017

    Article  PubMed  Google Scholar 

  3. Tikkinen KA, Johnson TM 2nd, Tammela TL, Sintonen H, Haukka J, Huhtala H et al (2010) Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur Urol 57:488–496

    Article  PubMed  Google Scholar 

  4. Rodrigues P, Meller A, Campagnari JC, Alcantara D, D’Imperio M (2004) International prostate symptom score–IPSS-AUA as discriminat scale in 400 male patients with lower urinary tract symptoms (LUTS). Int Braz J Urol 30:135–141

    Article  PubMed  Google Scholar 

  5. Barry MJ, Fowler FJ Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK (1995) Measuring disease-specific health status in men with benign prostatic hyperplasia: Measurement Committee of The American Urological Association. Med Care 33:AS145–AS155

    Article  PubMed  CAS  Google Scholar 

  6. Ware JE Jr, Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech P et al (1998) The factor structure of the SF-36 health survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 51:1159–1165

    Article  PubMed  Google Scholar 

  7. Tengs TO, Wallace A (2000) One thousand health-related quality-of-life estimates. Med Care 38:583–637

    Article  PubMed  CAS  Google Scholar 

  8. Hernandez Fernandez C, Ristol Pont J, Estivill E, Batista Miranda JE, Lopez Aramburu MA (2007) Importance of nocturia and its impact on quality of sleep and quality of life in patient with benign prostatic hyperplasia. Actas Urol Esp 31:262–269

    Article  PubMed  CAS  Google Scholar 

  9. Berges RR, Pientka L, Hofner K, Senge T, Jonas U (2001) Male lower urinary tract symptoms and related health care seeking in Germany. Eur Urol 39:682–687

    Article  PubMed  CAS  Google Scholar 

  10. Berges RR, Pientka L (1999) Management of the BPH syndrome in Germany: who is treated and how? Eur Urol 36(Suppl 3):21–27

    Article  PubMed  Google Scholar 

  11. Berges R (2008) Epidemiology of benign prostatic syndrome. Associated risks and management data in German men over age 50. Urol A 47:141–148

    Article  CAS  Google Scholar 

  12. Hutchison A, Farmer R, Verhamme K, Berges R, Navarrete RV. The efficacy of drugs for the treatment of LUTS/BPH, a study in 6 European countries. Eur Urol. 2007;51:207-15; discussion 15-6

  13. Lowe FC, Batista J, Berges R, Chartier-Kastler E, Conti G, Desgrandchamps F et al (2005) Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion. Prostate Cancer Prostatic Dis 8:206–209

    Article  PubMed  CAS  Google Scholar 

  14. Speakman M, Batista J, Berges R, Chartier-Kastler E, Conti G, Desgrandchamps F et al (2005) Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise. Prostate Cancer Prostatic Dis 8:369–374

    Article  PubMed  CAS  Google Scholar 

  15. Berges R, Dreikorn K, Hofner K, Madersbacher S, Michel MC, Muschter R et al (2009) Diagnostic and differential diagnosis of benign prostate syndrome (BPS): guidelines of the German Urologists. Urol A 48:1356–1360 62–64

    Article  CAS  Google Scholar 

  16. Berges R, Oelke M (2011) Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older. World J Urol 29:171–178

    Article  PubMed  Google Scholar 

  17. Koyanagi T, Artibani W, Correa R, Desgranchamps F, DeReijke TM, Govier F et al (1997) Initial diagnostic evaluation of men with lower urinary tract symptoms. 1989:258–60. In: Benign Prostatic Hyperplasia (BPH), 4th International Consultation on benign prostatic hyperplasia (BPH), Paris, July 2–5, 1997, Griffiths K, Denis L, Khoury S, Cockett ATK, McConnell J, Chatelain C, Murphy G, Yoshida O, Plymbridge Distributors, Plymouth

  18. Ware J Jr, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233

    Article  PubMed  Google Scholar 

  19. Ware JE, Kosinski M, Turner-Bowker DM, Gandek B (2002) How to Score Version 2 of the SF-12v2® Health Survey (With a Supplement Documenting SF-12® Health Survey). QualityMetric Incorporated, Lincoln

    Google Scholar 

  20. German Federal Statistics Office (Statistisches Bundesamt) 2012. http://www.bpb.de/wissen/X39RH6,0,0,Bev%F6lkerung_nach_Altersgruppen_und_Geschlecht.html. Assessed 8 June 2014

  21. Bosch JL, Weiss JP (2013) The prevalence and causes of nocturia. J Urol 189:S86–S92

    Article  PubMed  Google Scholar 

  22. Clark JA, Inui TS, Silliman RA, Bokhour BG, Krasnow SH, Robinson RA et al (2003) Patients’ perceptions of quality of life after treatment for early prostate cancer. J Clin Oncol 21:3777–3784

    Article  PubMed  Google Scholar 

  23. Homma Y, Yamaguchi T, Kondo Y, Horie S, Takahashi S, Kitamura T (2002) Significance of nocturia in the International prostate symptom score for benign prostatic hyperplasia. J Urol 167:172–176

    Article  PubMed  Google Scholar 

  24. Chen FY, Dai YT, Liu CK, Yu HJ, Liu CY, Chen TH (2007) Perception of nocturia and medical consulting behavior among community-dwelling women. Int Urogynecol J 18:431–436

    Article  Google Scholar 

Download references

Acknowledgments

The authors thank the German Working Group on BPH of the German Society of Urology for sponsoring the study from 1999 to 2005. The analyses shown in this article originate from data obtained in the follow-up visits of the original study.

Conflict of interest

Matthias Oelke is a consultant, speaker, and/or trial investigator in the field of LUTS/BPH for Apogepha, Astellas, Ferring, GlaxoSmithKline, Lilly, Mundipharma, Pfizer, and Recordati. Birgitt Wiese has no conflicts of interests. Richard Berges is consultant, speaker, and/or trial investigator in the field of LUTS/BPH for Astellas, Ferring, GlaxoSmithKline, Lilly, Pfizer, and Recordati.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthias Oelke.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oelke, M., Wiese, B. & Berges, R. Nocturia and its impact on health-related quality of life and health care seeking behaviour in German community-dwelling men aged 50 years or older. World J Urol 32, 1155–1162 (2014). https://doi.org/10.1007/s00345-014-1374-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-014-1374-6

Keywords

Navigation